{"id":6915,"date":"2020-11-27T11:36:55","date_gmt":"2020-11-27T11:36:55","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=6915"},"modified":"2020-11-27T11:39:30","modified_gmt":"2020-11-27T11:39:30","slug":"kovid-19-asi-yarisindaki-biyoteknoloji-ve-ilac-sirketleri-yatirimcilarin-radarinda","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/kovid-19-asi-yarisindaki-biyoteknoloji-ve-ilac-sirketleri-yatirimcilarin-radarinda\/","title":{"rendered":"Kovid-19 a\u015f\u0131 yar\u0131\u015f\u0131ndaki biyoteknoloji ve ila\u00e7 \u015firketleri yat\u0131r\u0131mc\u0131lar\u0131n radar\u0131nda"},"content":{"rendered":"

WASHINGTON (AA) – Yeni tip koronavir\u00fcse (Kovid-19) kar\u015f\u0131 y\u00fcr\u00fct\u00fclen a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 insanl\u0131\u011fa umut olurken, a\u015f\u0131 yar\u0131\u015f\u0131ndaki BioNTech, Pfizer, Curevac, Moderna, Astra-Zeneca, Johnson & Johnson, Novavax gibi biyoteknoloji ve ila\u00e7 firmalar\u0131n\u0131n hisselerinde ya\u015fanan hareketlilik de dikkati \u00e7ekiyor.<\/p>\n

\u0130nsan sa\u011fl\u0131\u011f\u0131n\u0131n yan\u0131 s\u0131ra \u00fclkeleri de tehdit eden Kovid-19, ekonomilerde \u0130kinci D\u00fcnya Sava\u015f\u0131’ndan beri g\u00f6r\u00fclmemi\u015f bir \u00e7\u00f6k\u00fc\u015fe neden oldu.Ekonomik \u00e7\u00f6k\u00fc\u015f, neredeyse t\u00fcm \u00fclke ekonomilerinde hissedilirken, \u00fclkeler bu \u00e7\u00f6k\u00fc\u015f\u00fc durdurmak i\u00e7in a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131na h\u0131z vermi\u015f durumda.<\/p>\n

K\u00fcresel salg\u0131na kar\u015f\u0131 korunmaya y\u00f6nelik a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 umut vadederken, D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019ne (WHO) g\u00f6re d\u00fcnyada 100’den fazla a\u015f\u0131 \u00fczerinde \u00e7al\u0131\u015fmalar da y\u00fcr\u00fct\u00fcl\u00fcyor.<\/p>

\"\"<\/a><\/div>\n

Kovid-19 a\u015f\u0131s\u0131na ili\u015fkin geli\u015fmeler piyasalar taraf\u0131ndan olumlu kar\u015f\u0131lan\u0131rken, a\u015f\u0131 yar\u0131\u015f\u0131na kat\u0131lan \u015firketlerin hisselerinin de de\u011fer kazanmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p>\n

K\u00fcresel a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131nda BioNTech ve Pfizer yar\u0131\u015f\u0131 \u00f6nde g\u00f6t\u00fcr\u00fcrken, halka a\u00e7\u0131k bir dizi \u015firket \u00e7al\u0131\u015fmalar\u0131yla bu yar\u0131\u015fta yer al\u0131yor.Aday a\u015f\u0131larla ilgili olarak, fiyatlar\u0131nda gelecek aylarda \u00f6nemli art\u0131\u015flar beklenirken, yat\u0131r\u0131mc\u0131lar i\u00e7in Kovid-19 salg\u0131n\u0131na dair umutlar\u0131n bir b\u00fct\u00fcn olarak analiz edilmesi \u00f6nem ta\u015f\u0131yor.<\/p>\n

Salg\u0131nla m\u00fccadelede gelecek aylarda BioNTech, Pfizer, Curevac, Moderna, Astra-Zeneca, Johnson & Johnson, Novavax gibi biyoteknoloji ve ila\u00e7 firmalar\u0131n\u0131n yat\u0131r\u0131mc\u0131lar\u0131n ilgi oda\u011f\u0131nda olaca\u011f\u0131 ifade ediliyor.<\/p>\n

Evercore ISI’n\u0131n analizinde, Kovid-19 a\u015f\u0131lar\u0131ndan \u015firketlerin 100 milyar dolar gelir elde edece\u011fi ve bu \u015firketlerin vergi sonras\u0131 toplam karlar\u0131n\u0131n da 40 milyar dolar olaca\u011f\u0131 kaydediliyor.<\/p>\n

BioNTech<\/p>\n

T\u00fcrk bilim insan\u0131 Prof. Dr. U\u011fur \u015eahin’in kurucu orta\u011f\u0131 oldu\u011fu Alman biyoteknoloji firmas\u0131 BioNTech, i\u015f birli\u011fi yapt\u0131\u011f\u0131 Amerikan ila\u00e7 \u015firketi Pfizer ile Kovid-19 a\u015f\u0131s\u0131n\u0131n pozitif etkisine ili\u015fkin verileri payla\u015fan ilk a\u015f\u0131 geli\u015ftiricileri oldu.<\/p>\n

BioNTech ve Pfizer, 9 Kas\u0131m’da Kovid-19’a kar\u015f\u0131 geli\u015ftirmekte olduklar\u0131 potansiyel a\u015f\u0131n\u0131n vir\u00fcse kar\u015f\u0131 y\u00fczde 90\u2019dan fazla etkili oldu\u011funu duyurdu.<\/p>\n

Bu bulgunun, herhangi bir Kovid-19 a\u015f\u0131s\u0131n\u0131n, ticari olarak ruhsatland\u0131rmadan \u00f6nceki son a\u015fama olan 3. a\u015fama denemelerindeki ilk ba\u011f\u0131ms\u0131z analizinin sonucu oldu\u011fu belirtildi.<\/p>\n

Y\u00fczde 90’\u0131n \u00fczerindeki etkililik oran\u0131 ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) ve uzmanlar\u0131n beklentilerini a\u015farken, a\u015f\u0131n\u0131n piyasaya sunulmas\u0131 i\u00e7in gerekli acil durum onay\u0131n\u0131n da \u00f6n\u00fcn\u00fc a\u00e7t\u0131.<\/p>\n

\u0130ki \u015firketin a\u00e7\u0131klamas\u0131n\u0131n ard\u0131ndan, BioNTech’in hisseleri yakla\u015f\u0131k y\u00fczde 24 de\u011fer kazanarak 115 dolara y\u00fckseldi. \u015eirketin hisseleri 25 Kas\u0131m itibar\u0131yla104 dolar\u0131n alt\u0131nda i\u015flem g\u00f6r\u00fcyordu.<\/p>\n

2008\u2019de kurulan BioNTech, Kovid-19 salg\u0131n\u0131 \u00f6ncesi kanser gibi ciddi hastal\u0131klara y\u00f6nelik ila\u00e7 geli\u015ftirmek i\u00e7in \u00e7al\u0131\u015fmalar yap\u0131yordu. \u015eirket, hisselerini ge\u00e7en y\u0131l ABD\u2019de Nasdaq borsas\u0131nda 15 dolardan halka arz ederek, 150 milyon dolar toplam\u0131\u015ft\u0131. \u015eirketin de\u011feri ise 3.39 milyar dolar olarak a\u00e7\u0131klan\u0131rken, 25 Kas\u0131m itibar\u0131yla \u015firketin piyasa de\u011feri 25 milyar dolarda bulunuyordu.<\/p>\n

BioNTech, ayr\u0131ca mRNA tabanl\u0131 \u201cBNT162′ a\u015f\u0131s\u0131n\u0131n \u00c7in\u2019de geli\u015ftirilmesinde, klinik testlerinin yap\u0131lmas\u0131nda ve pazarlanmas\u0131nda Shanghai Fosun Pharmaceutical (Fosun Pharma) ile i\u015f birli\u011fi yap\u0131yor.<\/p>\n

Pfizer, Biontech ve \u00c7inli ortaklar\u0131 Fosun’un a\u015f\u0131yla gelecek 10 y\u0131l i\u00e7ince 50 milyar dolara yak\u0131n sat\u0131\u015f yapabilece\u011fi tahmin edilirken, potansiyel getirisinin daha fazla olabilece\u011fi belirtiliyor.<\/p>\n

Pfizer<\/p>\n

BioNTech ile ortakla\u015fa geli\u015ftirilen Kovid-19 a\u015f\u0131s\u0131n\u0131n ba\u015far\u0131s\u0131, Amerikal\u0131 ila\u00e7 \u015firketi Pfizer’\u0131n da hisselerinin keskin bir \u015fekilde y\u00fckselmesini sa\u011flad\u0131.<\/p>\n

Son d\u00f6nemde y\u0131ll\u0131k 44 milyar dolar\u0131 a\u015fan sat\u0131\u015flar\u0131yla d\u00fcnyan\u0131n en b\u00fcy\u00fck ila\u00e7 \u015firketlerinden Pfizer’da hisse fiyatlar\u0131ndaki geli\u015fmeyi Kovid-19 a\u015f\u0131s\u0131n\u0131n yan\u0131 s\u0131ra di\u011fer haberlerin de belirleyece\u011fi belirtiliyor.<\/p>\n

Pfizer’\u0131n Upjohn b\u00f6l\u00fcm\u00fcn\u00fc k\u00fcresel ila\u00e7 \u015firketi Mylan ile birle\u015ftirme iste\u011fi bu haberler aras\u0131ndar. Genel olarak birle\u015fmeler ve sat\u0131n almalar yoluyla b\u00fcy\u00fcme y\u0131llard\u0131r Pfizer’\u0131n hisse fiyat\u0131 i\u00e7in temel itici g\u00fc\u00e7leri olu\u015fturuyor. \u015eirketin 11 y\u0131l \u00f6nce a\u015f\u0131 geli\u015ftiricisi Wyeth’in 68 milyar dolarl\u0131k devral\u0131nmas\u0131yla \u00f6nde gelen a\u015f\u0131 \u00fcreticileri ligine y\u00fckseldi\u011fi biliniyor.<\/p>\n

Pfizer’in a\u015f\u0131 b\u00f6l\u00fcm\u00fcn\u00fcn \u015fu anda 6,5 milyar dolarl\u0131k cirosu oldu\u011fu kaydediliyor.<\/p>\n

Pfizer’\u0131n BioNTech ile geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131s\u0131n\u0131n onay almas\u0131yla \u00f6nemli sat\u0131\u015f ve kazan\u00e7 f\u0131rsatlar\u0131 bu \u015firketleri bekliyor.<\/p>\n

Gelecek y\u0131l 1,3 milyar Kovid-19 a\u015f\u0131s\u0131n\u0131n \u00fcretilmesi hedeflenirken, ABD’de ilk 100 milyon a\u015f\u0131n\u0131n birim fiyat\u0131n\u0131n 19,5 dolar olmas\u0131 s\u00f6z konusu.<\/p>\n

Analistler, Pfizer ve Biontech ortakl\u0131\u011f\u0131n\u0131n gelecek 10 y\u0131l i\u00e7inde Covid-19 a\u015f\u0131lar\u0131yla elde edebilece\u011fi k\u00fcm\u00fclatif sat\u0131\u015flar\u0131n 40 milyar dolara varmas\u0131n\u0131 bekliyor.<\/p>\n

Moderna<\/p>\n

BioNTech ve Pfizer’\u0131n ard\u0131ndan Amerikan biyoteknoloji \u015firketi Moderna’dan da Kovid-19’a kar\u015f\u0131 geli\u015ftirilen a\u015f\u0131yla ilgili \u00fcmit verici haber geldi. Moderna, 16 Kas\u0131m’da hala s\u00fcren \u00e7al\u0131\u015fmadan elde edilen ilk verinin a\u015f\u0131s\u0131n\u0131n y\u00fczde 95,4 etkili oldu\u011funu ortaya koydu\u011funu a\u00e7\u0131klad\u0131.<\/p>\n

\u015eirketin Kovid-19 a\u015f\u0131s\u0131n\u0131n yan\u0131 s\u0131ra ba\u015fka a\u015f\u0131lar, kanser ila\u00e7lar\u0131 ve nadir metabolik bozukluklar i\u00e7in kullan\u0131lan ila\u00e7lar da dahil olmak \u00fczere bir dizi \u00fcr\u00fcn \u00fczerinde \u00e7al\u0131\u015ft\u0131\u011f\u0131 belirtiliyor.<\/p>\n

Kovid-19 a\u015f\u0131s\u0131na y\u00f6nelik proje ise ilk kez \u00f6nemli bir gelir vadediyor. ABD h\u00fck\u00fcmetinin 100 milyon dozluk Kovid-19 a\u015f\u0131s\u0131n\u0131n \u00fcretimi ve teslimi i\u00e7in Moderna ile 1,5 milyar dolarl\u0131k anla\u015fma yapt\u0131\u011f\u0131 bilinmekte.<\/p>\n

\u015eirketin \u00fczerine \u00e7al\u0131\u015ft\u0131\u011f\u0131 teknolojilerde ba\u015far\u0131l\u0131 olmas\u0131 halinde bu alandaki en iyi oyunculardan biri olaca\u011f\u0131na dikkat \u00e7ekiliyor.<\/p>\n

AstraZeneca<\/p>\n

Pfizer ve BioNTech ile Moderna’n\u0131n a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131na ili\u015fkin payla\u015ft\u0131\u011f\u0131 olumlu geli\u015fmelerin ard\u0131ndan \u0130ngiliz ve \u0130sve\u00e7 ortakl\u0131\u011f\u0131ndaki ila\u00e7 \u015firketi AstraZeneca’n\u0131n hisselerinde ise ge\u00e7en g\u00fcnlerde d\u00fc\u015f\u00fc\u015f g\u00f6r\u00fcld\u00fc.<\/p>\n

AstraZeneca’n\u0131n Oxford \u00dcniversitesi ile ortakla\u015fa geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131 projesi en geli\u015fmi\u015f projelerden biri olarak nitelendirilirken, k\u00fcresel talebi kar\u015f\u0131lamak i\u00e7in bir\u00e7ok a\u015f\u0131ya ihtiya\u00e7 olaca\u011f\u0131 ve bu nedenle AstraZeneca’n\u0131n da \u00e7al\u0131\u015fmalar\u0131n\u0131n \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131 belirtiliyor.<\/p>\n

Son d\u00f6nemde ya\u015fanan d\u00fc\u015f\u00fc\u015fe ra\u011fmen, \u015firketin hisselerinin a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 nedeniyle Kovid-19 salg\u0131n\u0131n\u0131n ba\u015f\u0131ndan bu yana \u00e7ift haneli bir y\u00fckseli\u015f g\u00f6sterdi\u011fi biliniyor.<\/p>\n

AstraZeneca’n\u0131n ana faaliyet alan\u0131 ise kanser, kardiyovask\u00fcler ve solunum hastal\u0131klar\u0131na y\u00f6nelik ila\u00e7lardan olu\u015fuyor. Dolay\u0131s\u0131yla, \u015firketin ba\u015fl\u0131ca tedavi alanlar\u0131 ve \u00f6zellikle onkolojiden gelen haberler hisselerinin seyri i\u00e7in \u00f6nem ta\u015f\u0131yor.<\/p>\n

Y\u0131ll\u0131k sat\u0131\u015flar\u0131 \u00e7ift haneli olarak artan AstraZeneca’n\u0131n hisse fiyatlar\u0131n\u0131n da 5 y\u0131lda ikiye katlad\u0131\u011f\u0131 kaydediliyor. \u015eirketin Kovid-19 a\u015f\u0131s\u0131ndaki ba\u015far\u0131s\u0131n\u0131n bu performans\u0131n\u0131 daha da art\u0131rabilece\u011fine dikkat \u00e7ekiliyor.<\/p>\n

Johnson & Johnson<\/p>\n

Amerikal\u0131 t\u0131bbi malzeme ve ila\u00e7 \u00fcreticisi Johnson & Johnson (J&J) da Kovid-19 a\u015f\u0131s\u0131na y\u00f6nelik \u00e7al\u0131\u015fmalar\u0131 ile dikkati \u00e7ekiyor.<\/p>\n

Salg\u0131n\u0131n ortaya \u00e7\u0131kmas\u0131ndan bu yana \u015firketin hisseleri borsada kar\u0131\u015f\u0131k bir seyir izlerken, mevcut seviyede ocak ay\u0131 de\u011ferlerinin alt\u0131nda i\u015flem g\u00f6r\u00fcyor.<\/p>\n

A\u015f\u0131yla ilgili haberler \u015firketin hisselerini etkileyen geli\u015fmelerden sadece birini olu\u015fturuyor. \u00d6rne\u011fin Kovid-19 krizinde operasyonlar\u0131n ertelenmesiyle \u015firketin t\u0131bbi teknoloji b\u00f6l\u00fcm\u00fcndeki sat\u0131\u015flar\u0131n d\u00fc\u015fmesi hisselerini etkileyen fakt\u00f6rler aras\u0131nda yer al\u0131yor.<\/p>\n

Kovid-19 a\u015f\u0131s\u0131yla ilgili her \u015fey planland\u0131\u011f\u0131 gibi giderse, a\u015f\u0131n\u0131n gelecek y\u0131l\u0131n ba\u015flar\u0131nda piyasaya sunulabilece\u011fi belirtiliyor.<\/p>\n

Bununla birlikte, Kovid-19 a\u015f\u0131s\u0131n\u0131n salg\u0131n d\u00f6neminde olunmas\u0131 nedeniyle ba\u015flang\u0131\u00e7ta uygun fiyata sat\u0131laca\u011f\u0131 i\u00e7in d\u00fcnyan\u0131n en b\u00fcy\u00fck sa\u011fl\u0131k \u015firketlerinden olan Johnson & Johnson i\u00e7in ticari bir ba\u015far\u0131 olmayaca\u011f\u0131 kaydedilmekte.<\/p>\n

Novavax ve Curevac<\/p>\n

\u200b\u200b\u200b\u200b\u200b\u200bABD’li ila\u00e7 \u015firketi Novavax da a\u015f\u0131 umudundan b\u00fcy\u00fck \u00f6l\u00e7\u00fcde faydalanan \u015firketler aras\u0131nda. \u015eirketin may\u0131s ay\u0131 ortalar\u0131nda 17 dolardan i\u015flem g\u00f6ren hisseleri, yaz d\u00f6neminde 170 dolar seviyesine \u00e7\u0131kmas\u0131n\u0131n ard\u0131ndan 100 dolar band\u0131nda seyrediyor.<\/p>\n

Analistler, Novavax’\u0131n a\u015f\u0131s\u0131n\u0131n ba\u015far\u0131l\u0131 olmas\u0131 halinde hisselerinde hala iyile\u015fme alan\u0131 oldu\u011funu belirtiyor.<\/p>\n

Kovid-19 a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131n\u0131n oda\u011f\u0131ndaki bir ba\u015fka \u015firket ise Almanya merkezli CureVac olarak biliniyor. Ancak rakipleriyle kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda CureVac’\u0131n \u00e7al\u0131\u015fmalarda bir ka\u00e7 ay geriden geldi\u011fi kaydediliyor.<\/p>\n

Analistler, \u015firketin hisselerine ili\u015fkin olumlu de\u011ferlendirmelerde bulunurken, CureVac’\u0131n hedeflerini ger\u00e7ekle\u015ftirmesi durumunda geli\u015fme alan\u0131 oldu\u011funun da alt\u0131n\u0131 \u00e7iziyor.<\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

WASHINGTON (AA) – Yeni tip koronavir\u00fcse (Kovid-19) kar\u015f\u0131 y\u00fcr\u00fct\u00fclen a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 insanl\u0131\u011fa umut olurken, a\u015f\u0131 yar\u0131\u015f\u0131ndaki BioNTech, Pfizer, Curevac, Moderna, Astra-Zeneca, Johnson & Johnson, Novavax gibi biyoteknoloji ve ila\u00e7 firmalar\u0131n\u0131n hisselerinde ya\u015fanan hareketlilik de dikkati \u00e7ekiyor. \u0130nsan sa\u011fl\u0131\u011f\u0131n\u0131n yan\u0131 s\u0131ra \u00fclkeleri de tehdit eden Kovid-19, ekonomilerde \u0130kinci D\u00fcnya Sava\u015f\u0131’ndan beri g\u00f6r\u00fclmemi\u015f bir \u00e7\u00f6k\u00fc\u015fe neden oldu.Ekonomik \u00e7\u00f6k\u00fc\u015f, neredeyse t\u00fcm \u00fclke ekonomilerinde hissedilirken, \u00fclkeler bu \u00e7\u00f6k\u00fc\u015f\u00fc durdurmak i\u00e7in a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131na h\u0131z vermi\u015f durumda. K\u00fcresel salg\u0131na kar\u015f\u0131 korunmaya y\u00f6nelik a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 umut vadederken, D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019ne (WHO) g\u00f6re d\u00fcnyada 100’den fazla a\u015f\u0131 \u00fczerinde \u00e7al\u0131\u015fmalar da y\u00fcr\u00fct\u00fcl\u00fcyor. Kovid-19 a\u015f\u0131s\u0131na ili\u015fkin geli\u015fmeler piyasalar taraf\u0131ndan olumlu […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-6915","post","type-post","status-publish","format-standard","hentry","category-dunya"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/6915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=6915"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/6915\/revisions"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=6915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=6915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=6915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}